Out-of-pocket costs for GLP-1 medications vary widely — and the range is genuinely dramatic depending on whether you're going the brand-name or compounded route.
Brand-name medications (Wegovy, Zepbound, Ozempic)
Without insurance, brand-name GLP-1s typically run over $1,000 per month at retail pharmacy prices. With commercial insurance, your actual cost depends heavily on your plan — some people pay very little with a manufacturer savings card, while others face high copays or hit coverage limits. Manufacturer programs like Novo Nordisk's savings card (for Wegovy/Ozempic) and Eli Lilly's for Zepbound can help bridge gaps for eligible patients.
Compounded semaglutide and tirzepatide
Compounded versions — made by licensed 503B outsourcing facilities or through telehealth prescribers — run significantly lower. Many telehealth providers price compounded tirzepatide under $200 per month, with some maintenance-dose programs coming in even lower. These prices have generally been trending downward as the compounding market has matured.
What affects your actual cost:
One thing to keep in mind: medication access can shift with insurance changes or regulatory developments, so it's worth understanding your backup options before you need them.
If cost is a significant concern, **talk to your provider** about compounded alternatives, manufacturer savings programs, or whether your diagnosis qualifies you for better coverage.
Different ways people phrase this question. Each expands to the same answer.
Out-of-pocket costs for GLP-1 medications vary widely — and the range is genuinely dramatic depending on whether you're going the brand-name or compounded route.
Brand-name medications (Wegovy, Zepbound, Ozempic)
Without insurance, brand-name GLP-1s typically run over $1,000 per month at retail pharmacy prices. With commercial insurance, your actual cost depends heavily on your plan — some people pay very little with a manufacturer savings card, while others face high copays or hit coverage limits. Manufacturer programs like Novo Nordisk's savings card (for Wegovy/Ozempic) and Eli Lilly's for Zepbound can help bridge gaps for eligible patients.
Compounded semaglutide and tirzepatide
Compounded versions — made by licensed 503B outsourcing facilities or through telehealth prescribers — run significantly lower. Many telehealth providers price compounded tirzepatide under $200 per month, with some maintenance-dose programs coming in even lower. These prices have generally been trending downward as the compounding market has matured.
What affects your actual cost:
One thing to keep in mind: medication access can shift with insurance changes or regulatory developments, so it's worth understanding your backup options before you need them.
If cost is a significant concern, **talk to your provider** about compounded alternatives, manufacturer savings programs, or whether your diagnosis qualifies you for better coverage.
Out-of-pocket costs for GLP-1 medications vary widely — and the range is genuinely dramatic depending on whether you're going the brand-name or compounded route.
Brand-name medications (Wegovy, Zepbound, Ozempic)
Without insurance, brand-name GLP-1s typically run over $1,000 per month at retail pharmacy prices. With commercial insurance, your actual cost depends heavily on your plan — some people pay very little with a manufacturer savings card, while others face high copays or hit coverage limits. Manufacturer programs like Novo Nordisk's savings card (for Wegovy/Ozempic) and Eli Lilly's for Zepbound can help bridge gaps for eligible patients.
Compounded semaglutide and tirzepatide
Compounded versions — made by licensed 503B outsourcing facilities or through telehealth prescribers — run significantly lower. Many telehealth providers price compounded tirzepatide under $200 per month, with some maintenance-dose programs coming in even lower. These prices have generally been trending downward as the compounding market has matured.
What affects your actual cost:
One thing to keep in mind: medication access can shift with insurance changes or regulatory developments, so it's worth understanding your backup options before you need them.
If cost is a significant concern, **talk to your provider** about compounded alternatives, manufacturer savings programs, or whether your diagnosis qualifies you for better coverage.
Out-of-pocket costs for GLP-1 medications vary widely — and the range is genuinely dramatic depending on whether you're going the brand-name or compounded route.
Brand-name medications (Wegovy, Zepbound, Ozempic)
Without insurance, brand-name GLP-1s typically run over $1,000 per month at retail pharmacy prices. With commercial insurance, your actual cost depends heavily on your plan — some people pay very little with a manufacturer savings card, while others face high copays or hit coverage limits. Manufacturer programs like Novo Nordisk's savings card (for Wegovy/Ozempic) and Eli Lilly's for Zepbound can help bridge gaps for eligible patients.
Compounded semaglutide and tirzepatide
Compounded versions — made by licensed 503B outsourcing facilities or through telehealth prescribers — run significantly lower. Many telehealth providers price compounded tirzepatide under $200 per month, with some maintenance-dose programs coming in even lower. These prices have generally been trending downward as the compounding market has matured.
What affects your actual cost:
One thing to keep in mind: medication access can shift with insurance changes or regulatory developments, so it's worth understanding your backup options before you need them.
If cost is a significant concern, **talk to your provider** about compounded alternatives, manufacturer savings programs, or whether your diagnosis qualifies you for better coverage.